Your browser doesn't support javascript.
loading
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives.
Pepe Ribeiro de Souza, Camila; Bolzachini Santoni, Natália; Gomes de Melo, Thais; Jansen de Oliveira Figueiredo, Marcio; da Costa Darrieux, Francisco Carlos; Soares Piegas, Leopoldo; Ouriques Martins, Sheila.
Afiliación
  • Pepe Ribeiro de Souza C; MedInsight Decisions Health Care, São Paulo, SP, Brazil. Electronic address: camila.pepe@gruporesulta.com.br.
  • Bolzachini Santoni N; Boehringer Ingelheim, São Paulo, SP, Brazil.
  • Gomes de Melo T; Boehringer Ingelheim, São Paulo, SP, Brazil.
  • Jansen de Oliveira Figueiredo M; State University of Campinas, UNICAMP, Campinas, SP, Brazil.
  • da Costa Darrieux FC; Heart Institute InCor, São Paulo, SP, Brazil.
  • Soares Piegas L; Dante Pazzanese Institute, São Paulo, SP, Brazil.
  • Ouriques Martins S; Clinical Hospital of Porto Alegre Porto Alegre, RS, Brazil.
Value Health Reg Issues ; 8: 36-42, 2015 Dec.
Article en En | MEDLINE | ID: mdl-29698169
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Evaluation_studies / Health_economic_evaluation / Risk_factors_studies País/Región como asunto: America do sul / Brasil Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Evaluation_studies / Health_economic_evaluation / Risk_factors_studies País/Región como asunto: America do sul / Brasil Idioma: En Año: 2015 Tipo del documento: Article